Bardakçı Osman, Çelik Hakim, Özardalı İlyas, Uzunköy Ali
Isparta City Hospital - Department of Surgical Oncology - Isparta, Turkey.
Harran University - Medical Faculty - Department of Physiology - Sanliurfa, Turkey.
Acta Cir Bras. 2025 Jun 6;40:e403925. doi: 10.1590/acb403925. eCollection 2025.
To determine whether pinocembrin (PC) confers protective effects against experimentally induced intestinal ischemia-reperfusion (I/R) injury in rats.
Thirty Wistar albino rats were randomly divided into three groups (n = 10 each): sham (underwent laparotomy only); I/R (superior mesenteric artery occlusion for 60 min followed by 60 min reperfusion); and I/R + PC (5 mg/kg PC intraperitoneally before ischemia and again prior to reperfusion). Total antioxidant capacity (TAC), total oxidant status (TOS), and oxidative stress index (OSI) were measured in both plasma and intestinal tissue. Histopathological evaluation was performed using hematoxylin and eosin staining and a modified Chiu scoring system.
Although TAC values did not show significant intergroup differences (p > 0.05), TOS and OSI values were significantly lower in the I/R + PC group than in the I/R group (p < 0.05). Histologically, the I/R + PC group displayed noticeably reduced mucosal damage compared to the untreated I/R group. These results suggest that PC alleviates oxidative stress and improves histological outcomes in intestinal I/R.
PC exhibits a protective effect against intestinal I/R injury by decreasing oxidative stress and preserving tissue architecture. Further studies are warranted to optimize PC's dosing, timing, and mechanistic actions for clinical application.
确定松属素(PC)是否对实验诱导的大鼠肠缺血再灌注(I/R)损伤具有保护作用。
将30只Wistar白化大鼠随机分为三组(每组n = 10):假手术组(仅行剖腹术);I/R组(肠系膜上动脉阻断60分钟,随后再灌注60分钟);I/R + PC组(缺血前和再灌注前腹腔注射5 mg/kg PC)。测定血浆和肠组织中的总抗氧化能力(TAC)、总氧化状态(TOS)和氧化应激指数(OSI)。采用苏木精-伊红染色和改良的Chiu评分系统进行组织病理学评估。
虽然TAC值在组间无显著差异(p > 0.05),但I/R + PC组的TOS和OSI值显著低于I/R组(p < 0.05)。组织学上,与未治疗的I/R组相比,I/R + PC组的黏膜损伤明显减轻。这些结果表明,PC可减轻肠I/R中的氧化应激并改善组织学结果。
PC通过降低氧化应激和维持组织结构对肠I/R损伤具有保护作用。有必要进一步研究以优化PC在临床应用中的给药剂量、时间和作用机制。